| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | Oct 9, 2025 | UroGen Pharma Ltd. | CFO | Sell | 46.3 | -2,203 | -49.14% | ✗ | $37.1K |
| Mar 13, 2023 | Mar 14, 2023 | Galera Therapeutics, Inc. | CFO | Buy | 91.3 | +10,000 | 100.00% | ✗ | $19.6K |
| Jun 19, 2018 | Aug 15, 2018 | Verrica Pharmaceuticals Inc. | CFO | Buy | 91.3 | +3,000 | 100.00% | ✗ | $45K |